» Articles » PMID: 33623075

Comparing Different Approaches for Operationalizing Subjective Cognitive Decline: Impact on Syndromic and Biomarker Profiles

Overview
Journal Sci Rep
Specialty Science
Date 2021 Feb 24
PMID 33623075
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Subjective cognitive decline (SCD) has been proposed as a risk factor for future cognitive decline and dementia. Given the heterogeneity of SCD and the lack of consensus about how to classify this condition, different operationalization approaches still need to be compared. In this study, we used the same sample of individuals to compare  different SCD operationalization approaches. We included 399 cognitively healthy individuals from a community-based cohort. SCD was assessed through nine questions about memory and non-memory subjective complaints. We applied four approaches to operationalize SCD: two hypothesis-driven approaches and two data-driven approaches. We characterized the resulting groups from each operationalization approach using multivariate methods on comprehensive demographic, clinical, cognitive, and neuroimaging data. We identified two main phenotypes: an amnestic phenotype characterized by an Alzheimer's Disease (AD) signature pattern of brain atrophy; and an anomic phenotype, which was mainly related to cerebrovascular pathology. Furthermore, language complaints other than naming helped to identify a subgroup with subclinical cognitive impairment and difficulties in activities of daily living. This subgroup also showed an AD signature pattern of atrophy. The identification of SCD phenotypes, characterized by different syndromic and biomarker profiles, varies depending on the operationalization approach used. In this study we discuss how these findings may be used in clinical practice and research.

Citing Articles

Subjective cognitive and olfactory impairments predict different prospective dementia outcomes.

Cedres N, Olofsson J Chem Senses. 2024; 49.

PMID: 39298281 PMC: 11446720. DOI: 10.1093/chemse/bjae033.


Neuropsychological Assessment for Early Detection and Diagnosis of Dementia: Current Knowledge and New Insights.

Alzola P, Carnero C, Bermejo-Pareja F, Sanchez-Benavides G, Pena-Casanova J, Puertas-Martin V J Clin Med. 2024; 13(12).

PMID: 38929971 PMC: 11204334. DOI: 10.3390/jcm13123442.


Clinical predictors of Alzheimer's disease-like brain atrophy in individuals with memory complaints.

Karakasli A, Ozkan E, Karacam Dogan M, Cap D, Karaosmanoglu A, Karahan S Brain Behav. 2024; 14(5):e3506.

PMID: 38688882 PMC: 11061206. DOI: 10.1002/brb3.3506.


Examining the role of participant and study partner report in widely-used classification approaches of mild cognitive impairment in demographically-diverse community dwelling individuals: results from the Einstein aging study.

Chang K, Wang C, Nester C, Katz M, Byrd D, Lipton R Front Aging Neurosci. 2023; 15:1221768.

PMID: 38076542 PMC: 10702963. DOI: 10.3389/fnagi.2023.1221768.


Biomarkers of Alzheimer's Disease and Cerebrovascular Disease in Relation to Depressive Symptomatology in Individuals With Subjective Cognitive Decline.

Zapater-Fajari M, Diaz-Galvan P, Cedres N, Rydberg Sterner T, Ryden L, Sacuiu S J Gerontol A Biol Sci Med Sci. 2023; 79(2).

PMID: 37708068 PMC: 10803123. DOI: 10.1093/gerona/glad216.


References
1.
Jessen F, Amariglio R, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G . A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014; 10(6):844-52. PMC: 4317324. DOI: 10.1016/j.jalz.2014.01.001. View

2.
Diniz B, Butters M, Albert S, Dew M, Reynolds 3rd C . Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013; 202(5):329-35. PMC: 3640214. DOI: 10.1192/bjp.bp.112.118307. View

3.
Molinuevo J, Rabin L, Amariglio R, Buckley R, Dubois B, Ellis K . Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement. 2016; 13(3):296-311. PMC: 5344703. DOI: 10.1016/j.jalz.2016.09.012. View

4.
Reisberg B, Gauthier S . Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int Psychogeriatr. 2007; 20(1):1-16. DOI: 10.1017/S1041610207006412. View

5.
Rabin L, Smart C, Crane P, Amariglio R, Berman L, Boada M . Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. J Alzheimers Dis. 2015; 48 Suppl 1:S63-86. PMC: 4617342. DOI: 10.3233/JAD-150154. View